-
1
Increased platelet aggregation in hepatic tissue of metabolic-associated fatty liver disease—an observational study
Published 2025-01-01Subjects: “…metabolic-associated fatty liver disease…”
Get full text
Article -
2
Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China
Published 2025-02-01Subjects: Get full text
Article -
3
-
4
Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
Published 2021-01-01Subjects: Get full text
Article -
5
-
6
Nonlinear relationship between hepatic steatosis index and reversion to normal glucose regulation in Chinese adults with prediabetes
Published 2025-02-01Subjects: Get full text
Article -
7
Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro
Published 2025-01-01Subjects: Get full text
Article -
8
A novel human specific lncRNA MEK6-AS1 regulates adipogenesis and fatty acid biosynthesis by stabilizing MEK6 mRNA
Published 2025-01-01Subjects: Get full text
Article -
9
-
10
Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis
Published 2021-09-01Subjects: Get full text
Article -
11
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
Published 2024-12-01Subjects: Get full text
Article